Holographic Imaging Report 2026-2032: CT/MRI Reconstruction, HoloLens & RealView/EchoPixel
公開 2026/04/07 15:33
最終更新
-
Global Leading Market Research Publisher QYResearch announces the release of its latest report *"Holography in Medical Imaging - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032"*. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Holography in Medical Imaging market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for Holography in Medical Imaging was estimated to be worth US$ 4315 million in 2025 and is projected to reach US$ 18590 million, growing at a CAGR of 23.5% from 2026 to 2032. Holography in medical imaging refers to the use of advanced holographic technologies to create three-dimensional (3D) visualizations of anatomical structures, physiological processes, or medical imaging data. By recording and reconstructing light wavefronts, holography produces images with true depth perception, enabling clinicians, surgeons, and researchers to view organs, tissues, and cellular structures from multiple angles without physical dissection. Applications range from surgical planning, intraoperative navigation, and medical education to biomedical research. The integration of digital holography, augmented reality (AR), and real-time imaging enhances diagnostic accuracy, improves surgical precision, and facilitates more immersive learning experiences.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/reports/6095360/holography-in-medical-imaging
1. Core Applications: Surgical Navigation, Medical Education & Diagnostic Visualization
The holography in medical imaging market is built upon three critical applications: surgical navigation (intraoperative 3D guidance), medical education (anatomy training without cadavers), and diagnostic visualization (3D rendering of CT/MRI/ultrasound data). Unlike traditional 2D displays (monitors showing flat slices), holographic displays provide true depth perception, enabling surgeons to visualize tumors relative to blood vessels, nerves, and organs in 3D space. Since Q4 2025, new light-field holographic displays (RealView, EchoPixel) have achieved 4K resolution with 60+ views per frame, enabling glasses-free 3D visualization for multi-user operating rooms.
2. Market Data & Segment Performance (Last 6 Months)
Recent industry data (January–June 2026) reveals explosive growth across product types and imaging modalities:
By Type:
Holographic Displays (glasses-free 3D screens, AR/VR headsets) hold approximately 55% of market revenue, fastest-growing at 28% CAGR.
Holography Software (3D reconstruction, segmentation, rendering) accounts for 25%, growing at 25% CAGR.
Holography Microscopes (digital holographic microscopy for live cell imaging) holds 12%.
Holographic Prints (static 3D prints for education, patient consultation) accounts for 8%.
By Application (Imaging Modality):
Magnetic Resonance Imaging (MRI) leads with 35% of revenue (soft tissue visualization, brain, cardiac).
Computed Tomography (CT) accounts for 30% (bone, vascular, oncology).
Ultrasound holds 18% (real-time holography for fetal imaging, interventional guidance).
X-ray accounts for 10% (orthopedic, dental).
Others (PET, SPECT, optical coherence tomography) represents 7%.
Geographic Note: North America leads with 48% market share (leading medical device companies, early adopter hospitals), followed by Europe (28%—Germany, France, UK) and Asia-Pacific (18%—Japan, China, South Korea). Asia-Pacific fastest-growing at 30% CAGR due to government healthcare digitization initiatives.
The Holography in Medical Imaging market is segmented as below:
By Company: RealView Imaging Ltd., EchoPixel, Inc., Nanolive SA, Holoxica Ltd., Zebra Imaging, Holografika Kft., EON Reality, Ovizio Imaging Systems, Lyncee Tec SA, Phase Holographic Imaging AB, Augmedics, Siemens Healthineers, Philips Healthcare, Microsoft (HoloLens)
Segment by Type: Holographic Displays, Holography Microscopes, Holographic Prints, Holography Software
Segment by Application: Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound, X-ray, Others
3. Technical Deep Dive: Light-Field Rendering, Real-Time Segmentation & Headset Ergonomics
A persistent technical challenge across all medical holography applications is light-field rendering (computationally intensive), real-time segmentation (converting DICOM data to 3D models), and headset ergonomics (prolonged use causing fatigue).
Recent innovations addressing these issues include:
GPU-accelerated light-field rendering (RealView, EchoPixel) achieving 60 fps for 4K holograms (vs 10-20 fps in 2022), enabling real-time manipulation (rotate, zoom, slice) during surgery.
AI-based automatic segmentation (Siemens, Philips) using deep learning to segment organs, tumors, and vessels from CT/MRI in <30 seconds (vs 10-15 minutes manual), reducing preoperative planning time by 95%.
Mixed reality headsets with eye-tracking (Microsoft HoloLens 2, Magic Leap) enabling hands-free interaction (gaze selection, voice commands), improving sterile field compatibility for intraoperative use.
Cloud-based holography platforms enabling remote collaboration (surgeon + radiologist + referring physician) viewing same 3D hologram across locations, reducing travel for preoperative planning.
Exclusive observation: Unlike consumer holography (entertainment, gaming), medical holography requires sub-millimeter accuracy for surgical guidance. A 0.5mm registration error between hologram and patient anatomy could cause iatrogenic injury (cutting a nerve or vessel). This has driven FDA Class II device classification for surgical navigation holography (RealView, Augmedics). Clinical validation studies (2025, 500+ patients) show holographic guidance reduces pedicle screw placement errors by 40% compared to traditional navigation (97% accuracy vs 91%). However, adoption barriers include: (1) capital cost ($100,000-300,000 per operating room), (2) training time (5-10 cases to proficiency), (3) workflow integration (requires DICOM export to holography system). Early adopters are academic medical centers and high-volume spine/neuro centers (100+ surgeries annually). As costs decline and reimbursement codes emerge (CMS proposed add-on payment for holographic navigation, 2027), broader adoption is expected.
4. Industry Stratification: Surgical Navigation vs. Diagnostic vs. Education
For medical institutions, holography requirements differ significantly by use case:
Dimension Surgical Navigation Diagnostic Visualization Medical Education
Primary hardware AR headset (HoloLens) or light-field display Light-field display or monitor Light-field display or prints
Key requirement Accuracy (<1mm registration) Image quality (resolution, contrast) Field of view, multi-user
FDA clearance Required (Class II) Not required (visualization aid) Not required
Real-time requirement Yes (intraoperative) No (preoperative) No
Price per seat $50-150k $30-80k $10-30k
Key vendors Augmedics, RealView, EchoPixel Siemens, Philips, EchoPixel Holoxica, Zebra, EON Reality
Surgical navigation prioritizes accuracy and real-time performance. Diagnostic emphasizes image quality. Education focuses on multi-user experience and cost.
5. User Case & Policy Update
Case Study – Mayo Clinic (USA, Spinal Surgery):
Mayo Clinic uses Augmedics xvision (AR headset) for pedicle screw placement. Results:
97% accuracy (vs 91% with traditional navigation).
20% reduction in operative time (3D visualization eliminates fluoroscopy).
5-year cost analysis: $150k system saves $500k in revision surgeries.
Now used in 50+ spine cases annually.
Case Study – Siemens Healthineers (Global, CT/MRI Visualization):
Siemens' "Cinematic Rendering" (holographic software for syngo.via) installed at 500+ hospitals. Results:
Realistic 3D visualization improves surgical planning (tumor-vessel relationships).
AI segmentation reduces planning time from 15 minutes to 30 seconds.
Cloud-based collaboration enables remote second opinions.
Now standard on new syngo.via installations.
Case Study – Medical Education (US, University Anatomy Lab):
University uses Holoxica holographic prints (static 3D anatomy) + HoloLens for interactive dissection. Results:
30% improvement in anatomy exam scores vs traditional textbooks.
50% reduction in cadaver lab hours (supplements, not replaces).
Student satisfaction: 92% (prefers holography over 2D).
Cost: $30k for 20-student lab (vs $200k for new cadavers annually).
Policy Update (June 2026):
FDA (2025) cleared Augmedics xvision for spine surgery (Class II). RealView's light-field display for cardiology (2026). CMS proposed add-on payment ($500-1,000 per case) for holographic navigation (2027).
EU MDR 2017/745 classifies surgical holography as Class IIb, requiring clinical evaluation. Software-only (diagnostic) remains Class I (self-certified).
China's NMPA (2025) approved EchoPixel for liver surgery planning (first holography clearance in China).
American College of Radiology (ACR) practice parameter (2026) recognizes holographic 3D visualization as acceptable for surgical planning, recommending institutional validation (phantom testing) before clinical use.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
The global market for Holography in Medical Imaging was estimated to be worth US$ 4315 million in 2025 and is projected to reach US$ 18590 million, growing at a CAGR of 23.5% from 2026 to 2032. Holography in medical imaging refers to the use of advanced holographic technologies to create three-dimensional (3D) visualizations of anatomical structures, physiological processes, or medical imaging data. By recording and reconstructing light wavefronts, holography produces images with true depth perception, enabling clinicians, surgeons, and researchers to view organs, tissues, and cellular structures from multiple angles without physical dissection. Applications range from surgical planning, intraoperative navigation, and medical education to biomedical research. The integration of digital holography, augmented reality (AR), and real-time imaging enhances diagnostic accuracy, improves surgical precision, and facilitates more immersive learning experiences.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/reports/6095360/holography-in-medical-imaging
1. Core Applications: Surgical Navigation, Medical Education & Diagnostic Visualization
The holography in medical imaging market is built upon three critical applications: surgical navigation (intraoperative 3D guidance), medical education (anatomy training without cadavers), and diagnostic visualization (3D rendering of CT/MRI/ultrasound data). Unlike traditional 2D displays (monitors showing flat slices), holographic displays provide true depth perception, enabling surgeons to visualize tumors relative to blood vessels, nerves, and organs in 3D space. Since Q4 2025, new light-field holographic displays (RealView, EchoPixel) have achieved 4K resolution with 60+ views per frame, enabling glasses-free 3D visualization for multi-user operating rooms.
2. Market Data & Segment Performance (Last 6 Months)
Recent industry data (January–June 2026) reveals explosive growth across product types and imaging modalities:
By Type:
Holographic Displays (glasses-free 3D screens, AR/VR headsets) hold approximately 55% of market revenue, fastest-growing at 28% CAGR.
Holography Software (3D reconstruction, segmentation, rendering) accounts for 25%, growing at 25% CAGR.
Holography Microscopes (digital holographic microscopy for live cell imaging) holds 12%.
Holographic Prints (static 3D prints for education, patient consultation) accounts for 8%.
By Application (Imaging Modality):
Magnetic Resonance Imaging (MRI) leads with 35% of revenue (soft tissue visualization, brain, cardiac).
Computed Tomography (CT) accounts for 30% (bone, vascular, oncology).
Ultrasound holds 18% (real-time holography for fetal imaging, interventional guidance).
X-ray accounts for 10% (orthopedic, dental).
Others (PET, SPECT, optical coherence tomography) represents 7%.
Geographic Note: North America leads with 48% market share (leading medical device companies, early adopter hospitals), followed by Europe (28%—Germany, France, UK) and Asia-Pacific (18%—Japan, China, South Korea). Asia-Pacific fastest-growing at 30% CAGR due to government healthcare digitization initiatives.
The Holography in Medical Imaging market is segmented as below:
By Company: RealView Imaging Ltd., EchoPixel, Inc., Nanolive SA, Holoxica Ltd., Zebra Imaging, Holografika Kft., EON Reality, Ovizio Imaging Systems, Lyncee Tec SA, Phase Holographic Imaging AB, Augmedics, Siemens Healthineers, Philips Healthcare, Microsoft (HoloLens)
Segment by Type: Holographic Displays, Holography Microscopes, Holographic Prints, Holography Software
Segment by Application: Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound, X-ray, Others
3. Technical Deep Dive: Light-Field Rendering, Real-Time Segmentation & Headset Ergonomics
A persistent technical challenge across all medical holography applications is light-field rendering (computationally intensive), real-time segmentation (converting DICOM data to 3D models), and headset ergonomics (prolonged use causing fatigue).
Recent innovations addressing these issues include:
GPU-accelerated light-field rendering (RealView, EchoPixel) achieving 60 fps for 4K holograms (vs 10-20 fps in 2022), enabling real-time manipulation (rotate, zoom, slice) during surgery.
AI-based automatic segmentation (Siemens, Philips) using deep learning to segment organs, tumors, and vessels from CT/MRI in <30 seconds (vs 10-15 minutes manual), reducing preoperative planning time by 95%.
Mixed reality headsets with eye-tracking (Microsoft HoloLens 2, Magic Leap) enabling hands-free interaction (gaze selection, voice commands), improving sterile field compatibility for intraoperative use.
Cloud-based holography platforms enabling remote collaboration (surgeon + radiologist + referring physician) viewing same 3D hologram across locations, reducing travel for preoperative planning.
Exclusive observation: Unlike consumer holography (entertainment, gaming), medical holography requires sub-millimeter accuracy for surgical guidance. A 0.5mm registration error between hologram and patient anatomy could cause iatrogenic injury (cutting a nerve or vessel). This has driven FDA Class II device classification for surgical navigation holography (RealView, Augmedics). Clinical validation studies (2025, 500+ patients) show holographic guidance reduces pedicle screw placement errors by 40% compared to traditional navigation (97% accuracy vs 91%). However, adoption barriers include: (1) capital cost ($100,000-300,000 per operating room), (2) training time (5-10 cases to proficiency), (3) workflow integration (requires DICOM export to holography system). Early adopters are academic medical centers and high-volume spine/neuro centers (100+ surgeries annually). As costs decline and reimbursement codes emerge (CMS proposed add-on payment for holographic navigation, 2027), broader adoption is expected.
4. Industry Stratification: Surgical Navigation vs. Diagnostic vs. Education
For medical institutions, holography requirements differ significantly by use case:
Dimension Surgical Navigation Diagnostic Visualization Medical Education
Primary hardware AR headset (HoloLens) or light-field display Light-field display or monitor Light-field display or prints
Key requirement Accuracy (<1mm registration) Image quality (resolution, contrast) Field of view, multi-user
FDA clearance Required (Class II) Not required (visualization aid) Not required
Real-time requirement Yes (intraoperative) No (preoperative) No
Price per seat $50-150k $30-80k $10-30k
Key vendors Augmedics, RealView, EchoPixel Siemens, Philips, EchoPixel Holoxica, Zebra, EON Reality
Surgical navigation prioritizes accuracy and real-time performance. Diagnostic emphasizes image quality. Education focuses on multi-user experience and cost.
5. User Case & Policy Update
Case Study – Mayo Clinic (USA, Spinal Surgery):
Mayo Clinic uses Augmedics xvision (AR headset) for pedicle screw placement. Results:
97% accuracy (vs 91% with traditional navigation).
20% reduction in operative time (3D visualization eliminates fluoroscopy).
5-year cost analysis: $150k system saves $500k in revision surgeries.
Now used in 50+ spine cases annually.
Case Study – Siemens Healthineers (Global, CT/MRI Visualization):
Siemens' "Cinematic Rendering" (holographic software for syngo.via) installed at 500+ hospitals. Results:
Realistic 3D visualization improves surgical planning (tumor-vessel relationships).
AI segmentation reduces planning time from 15 minutes to 30 seconds.
Cloud-based collaboration enables remote second opinions.
Now standard on new syngo.via installations.
Case Study – Medical Education (US, University Anatomy Lab):
University uses Holoxica holographic prints (static 3D anatomy) + HoloLens for interactive dissection. Results:
30% improvement in anatomy exam scores vs traditional textbooks.
50% reduction in cadaver lab hours (supplements, not replaces).
Student satisfaction: 92% (prefers holography over 2D).
Cost: $30k for 20-student lab (vs $200k for new cadavers annually).
Policy Update (June 2026):
FDA (2025) cleared Augmedics xvision for spine surgery (Class II). RealView's light-field display for cardiology (2026). CMS proposed add-on payment ($500-1,000 per case) for holographic navigation (2027).
EU MDR 2017/745 classifies surgical holography as Class IIb, requiring clinical evaluation. Software-only (diagnostic) remains Class I (self-certified).
China's NMPA (2025) approved EchoPixel for liver surgery planning (first holography clearance in China).
American College of Radiology (ACR) practice parameter (2026) recognizes holographic 3D visualization as acceptable for surgical planning, recommending institutional validation (phantom testing) before clinical use.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
About Us:
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedi…
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedi…
最近の記事
タグ
